Kodiak Sciences

NMQ:KOD · US50015M1099

BiotechnologySmall

360° View

Value66

Price/Sales11

Price/Earnings75

Price/Book93

Dividend Yield1

Growth84

Revenue Growth—

Profit Growth16

Capital Growth100

TSR 52w100

Safety54

Leverage22

Liquidity93

Refinancing43

Combined82

Sentiment49

Analyst Opinions70

Pro Holdings47

Opinion Changes79

Market Pulse4

Profile

CountryUSA

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeNASDAQGM

Founded2009

Employees95

Websitekodiak.com

ISINUS50015M1099

Last UpdateApr 2, 2026

Index & Theme

InflammationDiabetesArtificial IntelligenceOphthalmologyBiotechnologyHealth CareTherapeutics

Description

Kodiak Sciences Inc. (‘Kodiak’) operates as a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. The company devotes substantially all of its resources to the rese…

Analysis

Kodiak Sciences's 360° View rank of 82 places it among the strongest overall — better than 82% of its true peers.

It's a growth standout (84) and reasonably valued (66). On safety it is financially sound (54), and the market shows muted sentiment (49). Taken together, its Combined rank of 82 reads as among the strongest overall.

360° rank · history

1007550250

2026

All-time high

Jun 2026

All-time low

Mar 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Kodiak Sciences with its peers

Tyra Biosciences

NSQ:TYRA

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Connect Biopharma Holdings

NMQ:CNTB

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Surrozen

NAQ:SRZN

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Regenxbio

NSQ:RGNX

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

NovaBridge Biosciences

NMQ:NBP

—

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Cullinan Therapeutics

NSQ:CGEM

CountryUSA

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →